Cite

HARVARD Citation

    von Felden, J. et al. (2018). Editorial: genotype 3 HCV—who still needs ribavirin in a pan‐genotypic era? Authors' reply. Alimentary pharmacology & therapeutics. 47 (11), pp. 1550-1551. [Online]. 
  
Back to record